SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Del Mar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting